phrykt

KORU Medical Systems, Inc. (KRMD): who owns it and who trades it

As of Nov 16, 2026, KRMD insiders reported 8 purchases worth $215K in the last 12 months. The largest buyer was Adam R Kalbermatten (President), with $150K. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling KORU Medical Systems

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns KRMD

85 funds and institutions reported KRMD shares worth $86.9M at the end of Q2 2026, about 45% of the company. The largest holder is First Light Asset Management, LLC with 7.3%.

Funds and institutions (13F) 45%Everyone else 55%

10 largest owners, by share of the company

First Light Asset Management, LLC7.3%
Topline Capital Management, LLC7.3%
BlackRock, Inc.5.7%
Vanguard Capital Management LLC3.9%
Geode Capital Management, LLC2.4%
Simcoe Capital LLC1.8%
Meros Investment Management, LP1.6%
Lionhunter Capital Management, LLC1.5%
State Street Corp1.4%
Archon Capital Management LLC1.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
First Light Asset Management, LLC3.39M7.31%$14.2M-10%
Topline Capital Management, LLC3.37M7.28%$14.2M-4%
BlackRock, Inc.2.63M5.67%$11M+11%
Vanguard Capital Management LLC1.82M3.92%$7.6M+8%
Geode Capital Management, LLC1.13M2.43%$4.7M+7%
Simcoe Capital LLC827,3931.78%$3.5M+2%
Meros Investment Management, LP759,6641.64%$3.2M-0%
Lionhunter Capital Management, LLC693,1391.49%$2.9MNew
State Street Corp646,5721.39%$2.7M-0%
Archon Capital Management LLC642,9231.39%$2.7MNo change
Hrt Financial LP353,1720.76%$1.5MNew
Northern Trust Corp347,1730.75%$1.5M+8%
Vanguard Fiduciary Trust Co326,0970.70%$1.4M+6%
Morgan Stanley322,9590.70%$1.4M-12%
Vanguard Portfolio Management LLC309,8330.67%$1.3M+21%
White Pine Capital LLC284,1030.61%$1.2M+56%
Russell Investments Group, Ltd.269,5860.58%$1.1M-36%
Qube Research & Technologies Ltd199,9390.43%$840K+12%
Albion Financial Group186,3740.40%$783K-14%
Renaissance Technologies LLC164,9000.36%$693K+259%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, KRMD insiders reported $215K of open-market purchases and $0 of sales.

Purchases, 12 months
$215K
8 trades, 5 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Sep 8, 2026
Filed Sep 9, 2026

Purchases and sales by month

$101K$101KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 8, 2026Adam R KalbermattenChief Commercial OfficerPurchase32,000$3.16$101KForm 4
Jun 11, 2026Adam R KalbermattenPresidentPurchase7,500$3.93$29.5KForm 4
Jun 11, 2026Adam R KalbermattenPresidentPurchase5,000$3.96$19.8KForm 4
May 18, 2026Eric SchillerChief Technology OfficerPurchase5,000$3.91$19.6KForm 4
May 15, 2026Linda M TharbyCEOPurchase1,191$3.92$4.7KForm 4
May 14, 2026Christopher PazdanChief Operating OfficerPurchase5,000$3.88$19.4KForm 4
May 14, 2026Thomas Edward AdamsCFOPurchase459$3.90$1.8KForm 4
May 14, 2026Thomas Edward AdamsCFOPurchase5,041$3.86$19.5KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Adam R KalbermattenPresident-Chief Commercial Off$150K–Sep 8, 2026
Thomas Edward AdamsChief Financial Officer$21.2K–May 14, 2026
Eric SchillerChief Technology Officer$19.6K–May 18, 2026
Christopher PazdanChief Operating Officer$19.4K–May 14, 2026
Linda M TharbyChief Executive Officer, Director$4.7K–May 15, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

KRMD short interest

Low short interest. 1.9% of KRMD shares are sold short: about 1 share in 54. Over the last 12 reports the number of shares short went up 36%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 861,413 KRMD shares were sold short, 1.9% of the shares outstanding, down 3.0% from the report before. At the average daily volume of 131,562 shares, buying them all back would take about 6.5 trading days (days to cover).

Shares short, % of all shares

1.87%May 15Oct 302.25%

Days to cover

6.5May 15Oct 309.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026861,4131.87%-3%131,5626.5
Oct 15, 2026888,3941.92%-2%219,8864.0
Sep 30, 2026907,3881.97%-8%356,6342.5
Sep 15, 2026984,5882.13%+11%170,4715.8
Aug 31, 2026884,4931.92%+14%192,7604.6
Aug 14, 2026779,2521.69%-3%366,0402.1
Jul 31, 2026800,7541.73%-1%146,8475.5
Jul 15, 2026807,2081.74%+19%98,2088.2
Jun 30, 2026678,4841.46%-9%223,6033.0
Jun 15, 2026744,4801.61%+3%103,6467.2
May 29, 2026724,7601.56%+15%92,3247.8
May 15, 2026631,7811.36%+3%166,7833.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

KORU Medical Systems company events

KORU Medical Systems filed 12 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 10, 2026.

  1. Nov 10, 2026ResultsReleased financial results. Filing
  2. Aug 14, 2026RulesChanged its bylaws or articles. Filing
  3. Aug 5, 2026ResultsReleased financial results. Filing
  4. Jun 30, 2026AgreementKORU Medical Systems, Inc. entered into that certain Amendment No. 1 to Amended and Restated Manufacturing and Supply Agreement with Command Medical Products, LLC, which amends that certain Amended and Restated Manufacturing and Supply Agreement dated January 1, 2024 between the Company and Command. Filing
  5. May 21, 2026VoteReported shareholder vote results. Filing
  6. May 6, 2026ResultsReleased financial results. Filing
  7. Apr 3, 2026AgreementReference is made to the disclosure under Item 2.03 below which is hereby incorporated in this Item 1.01 by reference. Filing
  8. Mar 16, 2026LeadershipLinda Tharby, President and Chief Executive Officer of KORU Medical Systems, Inc., has announced her retirement as Chief Executive Officer effective June 30, 2026. Filing
  9. Mar 12, 2026ResultsReleased financial results. Filing
  10. Feb 11, 2026RulesChanged its bylaws or articles. Filing
  11. Jan 12, 2026ResultsReleased financial results. Filing
  12. Nov 25, 2025AgreementThe Company entered into an Amended and Restated Manufacturing and Supply Agreement with Command Medical Products, Inc., pursuant to which Command has agreed to manufacture and supply the Company’s subassemblies, needle sets and tubing products pursuant to the Company’s specifications and purchase… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

KORU Medical Systems financials

Famous investors that hold KRMD

3 of the 50 well-known investors we track reported holding KRMD in their latest 13F filing. The largest position is Jim Simons's, worth $691K.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026235,800$691K0.0%+43%
Ken Griffin · Citadel AdvisorsQ3 2026172,989$507K0.0%+507%
Israel Englander · Millennium ManagementQ3 202613,436$39.4K0.0%-18%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named KRMD in the last 120 days.

FiledHolderFormStake
Nov 16, 2026First Light Asset Management, LLC13G/A6.3%
Nov 16, 2026Topline Capital Management, LLC13G/A9.9%
Nov 16, 2026First Light Asset Management, LLC13G/A6.3%
Nov 16, 2026Topline Capital Management, LLC13G/A9.9%

Questions about KORU Medical Systems, Inc. (KRMD) stock

Who owns the most KRMD stock?

The largest reported owner of KORU Medical Systems, Inc. (KRMD) is First Light Asset Management, LLC, with 7.3% of the company. In total, 85 funds and institutions reported holding KRMD at the end of Q2 2026, together about 45% of the shares. See the largest owners.

Are KRMD insiders buying or selling?

In the last 12 months, KRMD insiders reported 8 open-market purchases worth $215K and no sales. The latest trade was on Sep 8, 2026. See every trade.

What is the short interest in KRMD?

As of Oct 30, 2026, 861,413 KRMD shares were sold short, 1.9% of the shares outstanding, down 3.0% from the report before. At the average daily volume of 131,562 shares, buying them all back would take about 6.5 trading days (days to cover). See the history.

Which famous investors hold KRMD?

3 of the 50 well-known investors we track reported KRMD in their latest 13F filing, including Jim Simons, Ken Griffin, Israel Englander. The largest position is worth $691K. See all holders.

Executive pay

KORU Medical Systems's chief executive was paid a total of $1.7M for the year ended Dec 31, 2025, up 37% from $1.3M the year before. In the last 12 months, KORU Medical Systems's executives and directors bought $215K of stock on the open market and sold none.

Chief executive, total pay$1.7MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$3.2MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.8MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.